6th International Congress on Tissue Engineering & Regenerative Medicine

The 6th International Congress on Tissue Engineering & Regenerative Medicine 2026 serves as a premier global platform for scientists, clinicians, researchers, and industry leaders to explore the transformative advancements in regenerative healthcare.

The congress will focus on a wide spectrum of topics including stem cell technologies, biomaterials, scaffolds, 3D bioprinting, gene editing, organ regeneration, and nanomedicine. It will provide a dynamic environment for participants to share pioneering discoveries, clinical experiences, and translational research that bridge the gap between the laboratory and real-world patient care.

Over the course of two days, the event will feature keynote speeches, expert panel discussions, interactive workshops, poster sessions, and B2B networking opportunities. Attendees will gain insights into how regenerative medicine is redefining therapeutic approaches across cardiovascular, orthopedic, neurological, and autoimmune diseases.

The conference also emphasizes the importance of academic–industry collaboration, highlighting how innovation, commercialization, and clinical application can work together to deliver next-generation therapies and improved patient outcomes.

Join us to be part of a global movement advancing the science of regeneration — where biology meets technology, and innovation transforms lives.

Market Analysis
The global regenerative medicine and tissue engineering industry is experiencing exponential growth, driven by the demand for innovative treatments that repair, replace, and regenerate damaged tissues and organs.

According to recent market reports:
The global regenerative medicine market was valued at USD 35 billion in 2024, and is expected to reach USD 90 billion by 2032, growing at a CAGR of 13.2%.
The tissue engineering segment alone accounts for nearly 30% of the market, supported by advancements in biomaterials, cell therapies, and biomanufacturing technologies.
Stem cell therapy and 3D bioprinting are among the fastest-growing areas, with increasing adoption in clinical applications and research.
North America remains the largest market due to strong R&D investments and FDA approvals, while Asia-Pacific is rapidly emerging with government-funded regenerative programs in Japan, South Korea, and China.
Major players include Organovo Holdings, Integra LifeSciences, Athersys, Medtronic, and Smith & Nephew, alongside growing participation from research institutions and biotech startups.
This congress aims to connect the scientific community with industry stakeholders to discuss new trends, identify investment opportunities, and foster strategic alliances shaping the regenerative healthcare economy of tomorrow.

Why to Attend
Gain Cutting-edge Knowledge:
Explore the latest research in tissue regeneration, cell-based therapies, and biomedical engineering from global experts and institutions.

Engage with Leaders:
Network with scientists, clinicians, engineers, and entrepreneurs driving the regenerative medicine revolution.

Showcase Your Research:
Present your findings through oral talks or posters, and gain international recognition among peers and industry professionals.

Collaborate and Innovate:
Build strategic partnerships for R&D, product development, clinical trials, and commercialization.

Shape the Future:
Understand regulatory frameworks, ethical considerations, and investment landscapes to help accelerate innovation in the field.

Global Visibility:
Get featured in conference proceedings, indexed journals, and digital media channels with global reach.

Who Should Attend
The conference is designed for professionals across the entire regenerative medicine ecosystem, including:
Researchers & Scientists: in stem cells, biomaterials, nanomedicine, and tissue regeneration.
Medical Practitioners & Surgeons: involved in orthopedics, neurology, cardiology, and reconstructive surgery.
Biotech & Pharma Executives: focusing on R&D, product innovation, and clinical applications.
Biomedical Engineers & Technologists: working on scaffold design, 3D printing, and tissue modeling.
Academicians & Students: pursuing careers in bioengineering, molecular biology, and life sciences.
Investors & Venture Capitalists: seeking innovative startups and translational projects.
Regulatory Experts & Policymakers: shaping ethical and legal frameworks in regenerative therapies.
Healthcare Innovators & Startups: developing new tools, diagnostics, and regenerative solutions.

Benefits of Participation
Certification: Earn an internationally recognized certificate for presentation or participation.
Publication Opportunities: Selected abstracts and research papers will be published in indexed journals and digital proceedings.
Networking Excellence: Meet over 300+ professionals from 40+ countries across academia, healthcare, and industry.
Knowledge Enrichment: Learn about breakthroughs that are transforming treatment protocols and patient recovery.
Brand Exposure: Showcase your organization, technology, or innovation before an international audience.
Collaborative Growth: Initiate research collaborations, industry partnerships, and funding discussions.
Career Advancement: Enhance your professional visibility and open doors to new research and funding opportunities.